STOCK TITAN

[Form 4] INCYTE CORP Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Incyte Corp (INCY) reported equity awards to David H. Gardner, EVP and Chief Strategy Officer, on 09/22/2025. The filing shows a grant of 9,429 restricted stock units (RSUs) that vest 25% annually over four years and are settled one-for-one in common stock. The report also lists 23,573 performance shares that can pay up to 200% of one share based on relative total shareholder return versus a fixed peer group over a three-year performance period beginning 01/01/2025, with earned shares vesting on the third anniversary. Additionally, 42,899 employee stock options were granted at an $84.73 exercise price, exercisable in 37 installments with the first 25% after one year and monthly vesting thereafter, expiring 09/22/2035. The filing shows the reporting person beneficially owned 9,429 common shares and had derivative interests underlying 23,573 performance shares and 42,899 options following the grants.

Incyte Corp (INCY) ha comunicato premi azionari a David H. Gardner, EVP e Chief Strategy Officer, il 22/09/2025. La documentazione mostra l’assegnazione di 9.429 RSU (restricted stock units) che maturano al 25% all’anno per quattro anni e sono liquidate one-for-one in azioni ordinarie. Il rapporto elenca anche 23.573 azioni performance che possono pagare fino al 200% di un’azione in base al rendimento totale per azionista relativo rispetto a un gruppo peer fisso su un periodo di prestazione di tre anni che inizia il 01/01/2025, con le azioni maturate che vestono al terzo anniversario. Inoltre, sono state concesse 42.899 stock option ai dipendenti con prezzo di esercizio di $84,73, esercitabili in 37 tranche con il primo 25% dopo un anno e vesting mensile successivo, scadendo il 22/09/2035. La documentazione mostra che la persona che riferisce possedeva beneficiamente 9.429 azioni ordinarie e aveva interessi derivati sottostanti 23.573 azioni performance e 42.899 opzioni dopo le assegnazioni.

Incyte Corp (INCY) informó sobre premios de acciones para David H. Gardner, vicepresidente ejecutivo y director de estrategia, el 22/09/2025. El archivo muestra una asignación de 9,429 unidades de acciones restringidas (RSU) que visten al 25% anual durante cuatro años y se liquidan uno a uno en acciones ordinarias. El informe también indica 23,573 acciones de rendimiento que pueden pagar hasta el 200% de una acción basada en el rendimiento total para los accionistas relativo frente a un grupo de pares fijo durante un período de rendimiento de tres años que comienza el 01/01/2025, con las acciones ganadas que vencerán en el tercer aniversario. Además, se concedieron 42,899 opciones sobre acciones para empleados con un precio de ejercicio de 84,73 USD, ejercitables en 37 cuotas con el primer 25% tras un año y consolidación mensual posterior, expirando el 22/09/2035. El archivo muestra que la persona informante poseía beneficiosamente 9,429 acciones comunes y tenía intereses derivados subyacentes a 23,573 acciones de rendimiento y 42,899 opciones tras las adjudicaciones.

Incyte Corp (INCY)는 2025년 9월 22일 David H. Gardner(부사장 겸 최고전략책임자)에게 주식 보상을 보고했습니다. 공시에는 4년 동안 매년 25%가 vesting되고 주식으로 1대 1로 settling되는 9,429개의 제한주식단위(RSU)가 포함되어 있습니다. 보고서에는 또한 3년 성과 기간(2025년 1월 1일 시작) 동안 고정된 동종 기업 그룹 대비 상대적 총주주수익률에 따라 최대 200%까지 지급될 수 있는 23,573주의 성과주식이 나와 있으며, 이는 3주년 실제 vesting에 해당 주식이 귀속됩니다. 또한 직원 주식매수선택권 42,899개가 행사가격 84.73달러로 부여되어 37개의 분할로 exercisable하며, 처음 25%는 1년 후에, 이후는 매월 vesting되며 2035년 9월 22일에 만료됩니다. 공시는 보고 당사자가 유익하게 9,429주를 보유하고 있으며, 23,573주의 성과주식 및 42,899주의 옵션에 파생적 이해관계가 있음을 보여줍니다.

Incyte Corp (INCY) a annoncé des attributions d’actions à David H. Gardner, vice-président exécutif et directeur de la stratégie, le 22/09/2025. Le dépôt indique une attribution de 9 429 RSU (restricted stock units) qui se vestent à hauteur de 25 % par an sur quatre ans et qui sont réglées en actions ordinaires au compte d’un pour un. Le rapport mentionne également 23 573 actions de performance qui peuvent payer jusqu’à 200 % d’une action en fonction du rendement total pour les actionnaires relatif à un groupe de pairs fixe sur une période de performance de trois ans à partir du 01/01/2025, les actions acquises se versonant au troisième anniversaire. De plus, 42 899 stock options pour employés ont été accordées avec un prix d'exercice de 84,73 $, exercitables en 37 tranches avec les premiers 25 % après un an et une attribution mensuelle par la suite, expirant le 22/09/2035. Le dossier indique que personne déclarant détenait bénéficiairement 9 429 actions ordinaires et détenait des intérêts dérivés sous-jacents à 23 573 actions de performance et à 42 899 options suite aux attributions.

Incyte Corp (INCY) meldete am 22.09.2025 Aktienzuteilungen an David H. Gardner, EVP und Chief Strategy Officer. Die Einreichung zeigt eine Gewährung von 9.429 RSUs (Restricted Stock Units), die über vier Jahre hinweg jährlich zu 25% vesten und eins-zu-eins in Stammaktien abgewickelt werden. Der Bericht listet außerdem 23.573 Performance-Aktien auf, die basierend auf dem relativen Total Shareholder Return gegenüber einer festen Peer-Gruppe über einen dreijährigen Leistungszeitraum ab dem 01.01.2025 bis zu 200% eines Anteils auszahlen können; verdiente Aktien vesten am dritten Jahrestag. Zusätzlich wurden 42.899 Employee Stock Options mit einem Ausübungspreis von 84,73 USD gewährt, exercisierbar in 37 Tranchen, wobei die ersten 25% nach einem Jahr und danach monatlich vesten, mit Ablauf am 22.09.2035. Die Einreichung zeigt, dass die meldende Person benefizient 9.429 Stammaktien hielt und derivative Interessen gegenüber 23.573 Performance-Aktien und 42.899 Optionen nach den Zuteilungen hatte.

أعلن شركة Incyte Corp (INCY) عن منح أسهم لدايفيد هـ. غاردنر، نائب الرئيس التنفيذي وكبير مسؤولي الإستراتيجية، في 22/09/2025. يبين الملف منحة 9,429 وحدة أسهم مقيدة (RSUs) تستحق بنسبة 25% سنوياً على مدى أربع سنوات وتُ settled واحد مقابل واحد في أسهم عادية. كما يذكر التقرير 23,573 سهم أداء يمكن أن تدفع حتى 200% من سهم واحد بناءً على العائد الإجمالي للمساهمين مقارنةً بمجموعة نظراء ثابتة على مدى ثلاث سنوات بدءاً من 01/01/2025، مع استحقاق الأسهم المكتسبة في الذكرى الثالثة. بالإضافة إلى ذلك، جُهّزت 42,899 خيار أسهم للموظفين بسعر ممارسة 84.73 دولار، وقابلة للممارسة على مدى 37 جزءاً مع 25% الأولى بعد عام واحد ثم vesting شهري لاحقاً، وتنتهي صلاحيتها في 22/09/2035. يظهر الملف أن الشخص المبلغ عنه يمتلك بشكل مفيد 9,429 سهماً عادياً وكان لديه مصالح مشتقة تستند إلى 23,573 سهم أداء و42,899 خياراً بعد المنح.

Incyte Corp (INCY) 于 2025/09/22 向 David H. Gardner,执行副总裁兼首席战略官,披露了股权奖励。 文件显示授予 9,429 股受限股票单位(RSU),在四年内每年归属 25%,并以一对一的方式以普通股结算。报告还列出 23,573 股绩效股票,基于相对于固定同业组别的相对股东回报在三年绩效期内可能支付高达一股的 200%,自 2025/01/01 起算,已归属的股票在第三个周年日归属。此外,授予员工股票期权 42,899 股,行使价 84.73 美元,分 37 次行使,首期在一年后归属 25%,随后按月归属,于 2035/09/22 到期。文件显示,汇报人受益持有 9,429 股普通股,并对 23,573 股绩效股和 42,899 股期权具有衍生权益。

Positive
  • 9,429 RSUs granted with explicit 25% annual vesting over four years, providing clear retention structure
  • 23,573 performance shares tied to relative TSR over a three-year period beginning 01/01/2025, with up to 200% payout, aligning pay with shareholder returns
  • 42,899 stock options granted at an $84.73 exercise price with a 09/22/2035 expiration and detailed 37-installment vesting schedule
Negative
  • None.

Insights

TL;DR: Executive received time-based RSUs, performance shares tied to TSR, and long-dated options; standard multi-year vesting structure.

The awards combine retention-focused RSUs with performance-based equity and long-duration options. The RSUs vest 25% annually over four years, aligning service retention incentives. Performance shares use a relative TSR metric over a three-year period beginning 01/01/2025 and can pay up to 200% per share, indicating a performance lever tied to peer-relative share price appreciation. The options carry an $84.73 exercise price and a ten-year term to 09/22/2035 with staged exercisability in 37 installments, which is a detailed staggered vesting schedule that blends initial cliff vesting with subsequent monthly vesting.

TL;DR: Grants reflect common governance practice: mix of service and performance awards with explicit vesting and performance periods.

The Form 4 discloses clear grant mechanics: RSUs settled one-for-one, performance shares tied to relative TSR versus a defined peer group, and option vesting specified in installments. The disclosure provides material grant sizes: 9,429 RSUs, 23,573 performance shares (each convertible up to 200%), and 42,899 options at $84.73. All holdings are reported as direct beneficial ownership post-grant. The filing is complete in describing vesting schedules and performance measurement windows, enabling stakeholders to assess timing and potential dilution from these awards.

Incyte Corp (INCY) ha comunicato premi azionari a David H. Gardner, EVP e Chief Strategy Officer, il 22/09/2025. La documentazione mostra l’assegnazione di 9.429 RSU (restricted stock units) che maturano al 25% all’anno per quattro anni e sono liquidate one-for-one in azioni ordinarie. Il rapporto elenca anche 23.573 azioni performance che possono pagare fino al 200% di un’azione in base al rendimento totale per azionista relativo rispetto a un gruppo peer fisso su un periodo di prestazione di tre anni che inizia il 01/01/2025, con le azioni maturate che vestono al terzo anniversario. Inoltre, sono state concesse 42.899 stock option ai dipendenti con prezzo di esercizio di $84,73, esercitabili in 37 tranche con il primo 25% dopo un anno e vesting mensile successivo, scadendo il 22/09/2035. La documentazione mostra che la persona che riferisce possedeva beneficiamente 9.429 azioni ordinarie e aveva interessi derivati sottostanti 23.573 azioni performance e 42.899 opzioni dopo le assegnazioni.

Incyte Corp (INCY) informó sobre premios de acciones para David H. Gardner, vicepresidente ejecutivo y director de estrategia, el 22/09/2025. El archivo muestra una asignación de 9,429 unidades de acciones restringidas (RSU) que visten al 25% anual durante cuatro años y se liquidan uno a uno en acciones ordinarias. El informe también indica 23,573 acciones de rendimiento que pueden pagar hasta el 200% de una acción basada en el rendimiento total para los accionistas relativo frente a un grupo de pares fijo durante un período de rendimiento de tres años que comienza el 01/01/2025, con las acciones ganadas que vencerán en el tercer aniversario. Además, se concedieron 42,899 opciones sobre acciones para empleados con un precio de ejercicio de 84,73 USD, ejercitables en 37 cuotas con el primer 25% tras un año y consolidación mensual posterior, expirando el 22/09/2035. El archivo muestra que la persona informante poseía beneficiosamente 9,429 acciones comunes y tenía intereses derivados subyacentes a 23,573 acciones de rendimiento y 42,899 opciones tras las adjudicaciones.

Incyte Corp (INCY)는 2025년 9월 22일 David H. Gardner(부사장 겸 최고전략책임자)에게 주식 보상을 보고했습니다. 공시에는 4년 동안 매년 25%가 vesting되고 주식으로 1대 1로 settling되는 9,429개의 제한주식단위(RSU)가 포함되어 있습니다. 보고서에는 또한 3년 성과 기간(2025년 1월 1일 시작) 동안 고정된 동종 기업 그룹 대비 상대적 총주주수익률에 따라 최대 200%까지 지급될 수 있는 23,573주의 성과주식이 나와 있으며, 이는 3주년 실제 vesting에 해당 주식이 귀속됩니다. 또한 직원 주식매수선택권 42,899개가 행사가격 84.73달러로 부여되어 37개의 분할로 exercisable하며, 처음 25%는 1년 후에, 이후는 매월 vesting되며 2035년 9월 22일에 만료됩니다. 공시는 보고 당사자가 유익하게 9,429주를 보유하고 있으며, 23,573주의 성과주식 및 42,899주의 옵션에 파생적 이해관계가 있음을 보여줍니다.

Incyte Corp (INCY) a annoncé des attributions d’actions à David H. Gardner, vice-président exécutif et directeur de la stratégie, le 22/09/2025. Le dépôt indique une attribution de 9 429 RSU (restricted stock units) qui se vestent à hauteur de 25 % par an sur quatre ans et qui sont réglées en actions ordinaires au compte d’un pour un. Le rapport mentionne également 23 573 actions de performance qui peuvent payer jusqu’à 200 % d’une action en fonction du rendement total pour les actionnaires relatif à un groupe de pairs fixe sur une période de performance de trois ans à partir du 01/01/2025, les actions acquises se versonant au troisième anniversaire. De plus, 42 899 stock options pour employés ont été accordées avec un prix d'exercice de 84,73 $, exercitables en 37 tranches avec les premiers 25 % après un an et une attribution mensuelle par la suite, expirant le 22/09/2035. Le dossier indique que personne déclarant détenait bénéficiairement 9 429 actions ordinaires et détenait des intérêts dérivés sous-jacents à 23 573 actions de performance et à 42 899 options suite aux attributions.

Incyte Corp (INCY) meldete am 22.09.2025 Aktienzuteilungen an David H. Gardner, EVP und Chief Strategy Officer. Die Einreichung zeigt eine Gewährung von 9.429 RSUs (Restricted Stock Units), die über vier Jahre hinweg jährlich zu 25% vesten und eins-zu-eins in Stammaktien abgewickelt werden. Der Bericht listet außerdem 23.573 Performance-Aktien auf, die basierend auf dem relativen Total Shareholder Return gegenüber einer festen Peer-Gruppe über einen dreijährigen Leistungszeitraum ab dem 01.01.2025 bis zu 200% eines Anteils auszahlen können; verdiente Aktien vesten am dritten Jahrestag. Zusätzlich wurden 42.899 Employee Stock Options mit einem Ausübungspreis von 84,73 USD gewährt, exercisierbar in 37 Tranchen, wobei die ersten 25% nach einem Jahr und danach monatlich vesten, mit Ablauf am 22.09.2035. Die Einreichung zeigt, dass die meldende Person benefizient 9.429 Stammaktien hielt und derivative Interessen gegenüber 23.573 Performance-Aktien und 42.899 Optionen nach den Zuteilungen hatte.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Gardner David H

(Last) (First) (Middle)
1801 AUGUSTINE CUT-OFF

(Street)
WILMINGTON DE 19803

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
INCYTE CORP [ INCY ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP, Chief Strategy Officer
3. Date of Earliest Transaction (Month/Day/Year)
09/22/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/22/2025 A 9,429(1) A $0 9,429(2) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Performance Shares (3) 09/22/2025 A 23,573 (3) 09/22/2028 Common Stock 23,573 $0 23,573 D
Employee Stock Option (right to buy) $84.73 09/22/2025 A 42,899 (4) 09/22/2035 Common Stock 42,899 $0 42,899 D
Explanation of Responses:
1. Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years. The RSUs may be settled only for shares of common stock on a one-for-one basis.
2. Includes the September 22, 2025 aggregate grant of 9,429 shares of common stock.
3. Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2025 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer.
4. The September 22, 2025 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.
Remarks:
/s/ Elizabeth Feeney, Attorney-In-Fact 09/24/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What equity awards did INCY grant to David H. Gardner on 09/22/2025?

The Form 4 reports grants of 9,429 RSUs, 23,573 performance shares (up to 200% payout per share), and 42,899 stock options at an $84.73 exercise price.

How do the RSUs awarded to the reporting person vest?

The 9,429 RSUs vest 25% annually over four years and are settled one-for-one in common stock.

What performance metric governs the performance shares in the INCY grant?

The 23,573 performance shares are earned based on the issuer's relative total shareholder return (TSR) over a three-year period beginning 01/01/2025 versus a fixed peer group.

What are the key terms of the stock options granted on 09/22/2025?

The 42,899 options have an $84.73 exercise price, become exercisable in 37 installments with the first 25% after one year, vest monthly thereafter, and expire on 09/22/2035.

How many shares did the reporting person beneficially own following the reported transactions?

The filing shows 9,429 shares of common stock beneficially owned following the September 22, 2025 grant, plus the derivative interests underlying the performance shares and options.
Incyte Corp

NASDAQ:INCY

INCY Rankings

INCY Latest News

INCY Latest SEC Filings

INCY Stock Data

15.95B
190.92M
2.03%
103.47%
3.85%
Biotechnology
Services-commercial Physical & Biological Research
Link
United States
WILMINGTON